Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 11,712 shares at $59.06 ($706K) on 2018-11-15, disclosed to the SEC on 2018-11-19.
Open-market sale of $706k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.46 | 2,170 | $127K | 18.0% |
| 2 | $58.46 | 2,170 | $127K | 18.0% |
| 3 | $59.06 | 1,900 | $112K | 15.9% |
| 4 | $60.40 | 588 | $36K | 5.0% |
| 5 | $62.23 | 2,042 | $127K | 18.0% |
| 6 | $62.23 | 2,042 |
| $127K |
| 18.0% |
| 7 | $63.05 | 700 | $44K | 6.3% |
| 8 | $64.10 | 100 | $6K | 0.9% |
| Total | $60.29 avg | 11,712 | $706K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |